Latest Influenza vaccines Stories
MERIDEN, Conn., May 13, 2015 /PRNewswire/ -- Protein Sciences Corporation announced that on May 12, 2015 the U.S.
Market Research Reports.biz now carries a research report titled, “Influenza Vaccines Market & Forecast - Worldwide Analysis” that delivers a comprehensive analysis of the global influenza
- The first and only four-strain influenza vaccine option administered intradermally - SWIFTWATER, Pa., Dec.
MERIDEN, Conn., Oct. 29, 2014 /PRNewswire/ -- Protein Sciences Corporation announced today that the U.S.
The makers of FluMist® Quadrivalent (Influenza Vaccine Live, Intranasal) and the "CSI: Cyber" star launch national campaign to dispel common misconceptions about flu and annual vaccination
Latest Analysis Provides Basis for a Synthetic Ebola Blocker-Vaccine Candidate, Now Available for Testing LONDON, Aug. 26, 2014 /PRNewswire/ -- An analysis by Replikins, Ltd.
New Analysis Provides Basis for a Synthetic Dengue Blocker-Vaccine Candidate Now Available for Testing LONDON, Aug. 26, 2014 /PRNewswire/ -- An analysis by Replikins, Ltd.
MarketReportsOnline.com adds "Global Influenza (Flu) Vaccine Market: Trends & Opportunities (2014-19)" report to its research store. Dallas, Texas
High-dose influenza vaccine is 24 percent more effective than the standard-dose vaccine in protecting persons ages 65 and over against influenza illness and its complications.
MERIDEN, Conn., July 8, 2014 /PRNewswire/ -- Protein Sciences Corporation announced today that the FDA has approved
- A woman chauffeur.
- A woman who operates an automobile.